FDA OKs Pfizer-BioNTech Booster For People 65+ And At High Risk For Severe COVID

By Scott Hensley

Published September 22, 2021 at 7:52 PM EDT

Facebook
Twitter
LinkedIn
Email

Facebook
Twitter
LinkedIn
Email

Scott Hensley

Scott Hensley edits stories about health, biomedical research and pharmaceuticals for NPR's Science desk. During the COVID-19 pandemic, he has led the desk's reporting on the development of vaccines against the coronavirus.

See stories by Scott Hensley